Thymus-based tolerogenic approaches for type I diabetes.

Details for Australian Patent Application No. 2003266331 (hide)

Owner Universite de Liege

Inventors Geenen, Vincent

Agent Griffith Hack

Pub. Number AU-B-2003266331

PCT Number PCT/EP03/09623

PCT Pub. Number WO2004/019965

Priority 60/407,273 30.08.02 US; 60/438,029 02.01.03 US; 60/432,295 09.12.02 US

Filing date 28 August 2003

Wipo publication date 19 March 2004

Acceptance publication date 7 August 2008

International Classifications

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

18 December 2003 Complete Application Filed

  Priority application(s): 60/407,273 30.08.02 US; 60/438,029 02.01.03 US; 60/432,295 09.12.02 US

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2003266331

7 August 2008 Application Accepted

  Published as AU-B-2003266331

4 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003266332-METHOD FOR MIXING A POLYOL CONSTITUENT AND AN ISOCYANATE CONSTITUENT

2003266330-HETEREOARYL NITRILE DERIVATIVES